
zzso tract zzso zzso are a zzso group of zzso with a historically poor prognosis as a zzso Until recently, the development of effective zzso was hampered by the relatively low zzso zzso in patients and tumors, and zzso poor clinical trial zzso With the publication of the landmark phase III zzso trial demonstrating the superiority of zzso and zzso combination chemotherapy, the landscape changed for the development of new zzso Despite this progress, there are currently no approved targeted agents for zzso This review will focus on recent developments in targeted zzso directed against several key signaling pathways in zzso including zzso growth factor zzso zzso and the zzso protein zzso zzso Data from recent phase I and II trials will be discussed, along with a preview of upcoming trials involving targeted zzso 

